Publication | Open Access
A Prospective Study of Self-Reported Sleep Duration and Incident Diabetes in Women
888
Citations
18
References
2003
Year
Short-term sleep restriction impairs glucose tolerance. The study examined whether habitual short sleep increases diabetes risk in 70,026 women from the Nurses Health Study. Women were followed from 1986 to 1996 for incident diabetes (1,969 cases) and a separate analysis of 1,187 symptomatic cases. Short and long sleep durations were linked to higher diabetes risk; after BMI adjustment the risk for short sleepers was no longer significant, while long sleepers remained modestly elevated, and symptomatic diabetes risk was similarly increased for both groups.
Short-term sleep restriction results in impaired glucose tolerance. To test whether habitually short sleep duration increases the risk of developing diabetes, we studied a cohort of 70,026 women enrolled in the Nurses Health Study, without diabetes at baseline, and who responded to a question about daily sleep duration in 1986. Subjects were followed until 1996 for the diagnosis of diabetes (1,969 cases). Long and short sleep durations were associated with an increased risk of diabetes diagnosis. The relative risks (RRs) for short (slept ≤5 h per day) and long (slept ≥9 h per day) sleepers were 1.57 (95% CI 1.28–1.92) and 1.47 (1.19–1.80), respectively. After adjustment for BMI and a variety of confounders, the RR was not significantly increased for short sleepers (1.18 [0.96–1.44]) but remained modestly increased for long sleepers (1.29 [1.05–1.59]). We then performed a similar analysis using only symptomatic cases (n = 1,187). Adjusted RRs for symptomatic diabetes were modestly elevated in both short (1.34 [1.04–1.72]) and long (1.35 [1.04–1.75]) sleepers. Our data suggest that the association between a reduced self-reported sleep duration and diabetes diagnosis could be due to confounding by BMI, or sleep restriction may mediate its effects on diabetes through weight gain. Sleep restriction may be an independent risk factor for developing symptomatic diabetes.
| Year | Citations | |
|---|---|---|
Page 1
Page 1